Rezolve Ai to Participate in Upcoming Investor Conferences Hosted by RBC Capital Markets and Roth Capital Partners

Rezolve Ai to Participate in Upcoming Investor Conferences Hosted by RBC Capital Markets and Roth Capital Partners GlobeNewswire October 27, 2025 NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a leader in AI-powered commerce solutions, announced that it will participate in two upcoming investor conferences. Daniel M. Wagner, Rezolve Ai's Founder […]

Amneal Launches Brekiya(R) – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches

(NASDAQ:AMRX), Brekiya(R) autoinjector, a new specialty therapy from Amneal, is now available for prescription exclusively through Walgreens Specialty Pharmacy and Sterling Specialty Pharmacy BRIDGEWATER, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) — Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced the U.S. commercial launch of Brekiya(R) (dihydroergotamine mesylate) injection, the first and only

Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics GlobeNewswire October 27, 2025 Fort Lee, NJ, Oct. 27, 2025 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of

VirTra Sets Third Quarter 2025 Conference Call for Monday, November 10, 2025 at 4:30 p.m. ET

(NASDAQ:VTSI), CHANDLER, Ariz., Oct. 27, 2025 (GLOBE NEWSWIRE) — VirTra, Inc. (Nasdaq: VTSI) (“VirTra” or the “Company”), a global provider of judgmental use-of-force and firearms training simulators, will hold a conference call on Monday, November 10, 2025 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the third quarter

Comfort Is the New Beautiful: EKOUAER x Bedsure Launch New Collection to Redefine Comfort as a Lifestyle

Comfort Is the New Beautiful: EKOUAER x Bedsure Launch New Collection to Redefine Comfort as a Lifestyle GlobeNewswire October 27, 2025 NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) — Fresh off its 10th anniversary celebration, EKOUAER unveils a new milestone in collaboration with global home brand Bedsure, presenting a limited-edition collection built around the concept

Apyx Medical Corporation to Participate in Upcoming November Investor Conferences

(NASDAQ:APYX), CLEARWATER, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) — Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion(R) and the AYON Body Contouring System(TM), today announced that Charles Goodwin, President and CEO and Matt Hill, CFO will be attending the following

Creative Health Care Insight Announces Exclusive Partnership with Renowned Nursing Education Innovator Dr. Ellen Joswiak, Launching Revolutionary TSAM(R) Implementation Consulting Education

Creative Health Care Insight Announces Exclusive Partnership with Renowned Nursing Education Innovator Dr. Ellen Joswiak, Launching Revolutionary TSAM(R) Implementation Consulting Education Industry-First Partnership Will Launch the CHCI Exclusive Consulting Division and Nationwide Workshop Series Delivering the Evidence-Based Clinical Tiered Orientation Framework to Health Care Organizations GlobeNewswire October 27, 2025 Nashville, TN, Oct. 27, 2025 (GLOBE

TeleSpecialists Expands TeleEEG Service Line with Comprehensive Coverage Across All Study Types

Fort Myers, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) — TeleSpecialists, a physician-led digital healthcare solution provider, announced significant expansion of its TeleEEG remote interpretation services. The enhanced service line now includes point-of-care, ambulatory, and pediatric EEG studies in addition to the company's established routine, STAT, and long-term monitoring capabilities. The expansion seamlessly integrates subspecialty expertise

MicroCloud Hologram Inc. (NASDAQ: HOLO) Expects Full-Year 2025 Net Income to Exceed RMB 350 Million

MicroCloud Hologram Inc. (NASDAQ: HOLO) Expects Full-Year 2025 Net Income to Exceed RMB 350 Million GlobeNewswire October 27, 2025 SHENZHEN, China, Oct. 27, 2025 (GLOBE NEWSWIRE) — MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the “Company”), a technology service provider, anticipates achieving significant profitability for the full year 2025, with substantial year-over-year growth. The Company

Scroll to Top